A Querri1, A Ohkado1,2, S Yoshimatsu1,3, L Coprada4, E Lopez5, A Medina6, A Garfin4, J Bermejo7, F Tang8, A Shimouchi2,9. 1. Research Institute of Tuberculosis (RIT), Japan Anti-Tuberculosis Association (JATA) Philippines, Manila, The Philippines. 2. RIT/JATA, Tokyo, Japan. 3. Department of Paediatrics, National Hospital Organization Minami Kyoto Hospital, Kyoto, Japan. 4. Disease Prevention and Control Bureau, Department of Health, Manila, The Philippines. 5. Region Office 4A Calabarzon, Department of Health, Quezon City, The Philippines. 6. National Capital Region Office, Mandaluyong, The Philippines. 7. Manila Health Department, Manila, The Philippines. 8. Quezon City Health Department, Quezon City, The Philippines. 9. Osaka City Health Department, Osaka, Japan.
Abstract
Setting: The Research Institute of Tuberculosis/Japan Anti-Tuberculosis Association Philippines is a local non-governmental organisation (NGO) established in 2008 to improve access to tuberculosis (TB) services. Community health volunteers (CHVs) from NGO referring facilities were engaged to assist in local TB control activities. Objective: To describe the activities of the CHVs and the barriers experienced by patients with presumptive TB in seeking health care to treatment as documented on a master list, and to identify the CHVs' challenges in community TB care implementation. Design: This was a retrospective evaluation with a non-experimental design reviewing the presumptive TB master list and TB reports and conducting a free discussion session (FDS) in 2012. Results: Of the 78% (281/362) of referred presumptive TB patients who accessed a DOTS facility, 69% (194/281) underwent a diagnostic examination and 42% (81/194) were diagnosed with active TB. Of the 93% (75/81) initiated on treatment, 92% (69/75) were successfully treated. The CHVs contributed approximately 3% (75/2534) to the total TB cases diagnosed at the DOTS facilities. In the FDS, barriers evoked in seeking health care for treatment were transfer of residence and lack of interest in seeking a consultation. In 2012, the CHV attrition rate was 55% (80/145). Conclusion: The CHVs assisted in enhancing access to TB care and case detection. Sustainability of the CHVs' efforts should be explored to retain them in the programme.
Setting: The Research Institute of Tuberculosis/Japan Anti-Tuberculosis Association Philippines is a local non-governmental organisation (NGO) established in 2008 to improve access to tuberculosis (TB) services. Community health volunteers (CHVs) from NGO referring facilities were engaged to assist in local TB control activities. Objective: To describe the activities of the CHVs and the barriers experienced by patients with presumptive TB in seeking health care to treatment as documented on a master list, and to identify the CHVs' challenges in community TB care implementation. Design: This was a retrospective evaluation with a non-experimental design reviewing the presumptive TB master list and TB reports and conducting a free discussion session (FDS) in 2012. Results: Of the 78% (281/362) of referred presumptive TB patients who accessed a DOTS facility, 69% (194/281) underwent a diagnostic examination and 42% (81/194) were diagnosed with active TB. Of the 93% (75/81) initiated on treatment, 92% (69/75) were successfully treated. The CHVs contributed approximately 3% (75/2534) to the total TB cases diagnosed at the DOTS facilities. In the FDS, barriers evoked in seeking health care for treatment were transfer of residence and lack of interest in seeking a consultation. In 2012, the CHV attrition rate was 55% (80/145). Conclusion: The CHVs assisted in enhancing access to TB care and case detection. Sustainability of the CHVs' efforts should be explored to retain them in the programme.
Entities:
Keywords:
community volunteers; health access; health barriers; non-governmental organisation
Authors: T E Tupasi; S Radhakrishna; M I Quelapio; M L Villa; M L Pascual; A B Rivera; A Sarmiento; V M Co; J N Sarol; G Beltran; J D Legaspi; N V Mangubat; A C Reyes; M Solon; F S Solon; L Burton; M J Mantala Journal: Int J Tuberc Lung Dis Date: 2000-01 Impact factor: 2.373
Authors: P Kamolratanakul; H Sawert; S Kongsin; S Lertmaharit; J Sriwongsa; S Na-Songkhla; S Wangmane; S Jittimanee; V Payanandana Journal: Int J Tuberc Lung Dis Date: 1999-07 Impact factor: 2.373
Authors: R Rajeswari; R Balasubramanian; M Muniyandi; S Geetharamani; X Thresa; P Venkatesan Journal: Int J Tuberc Lung Dis Date: 1999-10 Impact factor: 2.373
Authors: V Singh; A Jaiswal; J D H Porter; J A Ogden; R Sarin; P P Sharma; V K Arora; R C Jain Journal: Trop Med Int Health Date: 2002-08 Impact factor: 2.622
Authors: Syed Moshfiqur Rahman; Nabeel Ashraf Ali; Larissa Jennings; M Habibur R Seraji; Ishtiaq Mannan; Rasheduzzaman Shah; Arif Billah Al-Mahmud; Sanwarul Bari; Daniel Hossain; Milan Krishna Das; Abdullah H Baqui; Shams El Arifeen; Peter J Winch Journal: Hum Resour Health Date: 2010-05-03
Authors: Andy Haines; David Sanders; Uta Lehmann; Alexander K Rowe; Joy E Lawn; Steve Jan; Damian G Walker; Zulfiqar Bhutta Journal: Lancet Date: 2007-06-23 Impact factor: 79.321
Authors: S C Meribe; E Harausz; I Lawal; A Ogundeji; C Mbanefo; Y Adamu; N A Hussain; L Chittenden; R Nelson Journal: Public Health Action Date: 2019-12-21